The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="7"><hr/></td></tr><tr class="thead"><td class="align_left">Study ID</td><td class="align_center">Trial identifier</td><td class="align_center">Author</td><td class="align_center">Year</td><td class="align_center">Country</td><td class="align_center">Disease</td><td class="align_center">Duration (W)</td></tr><tr><td class="thead-hr" colspan="7"><hr/></td></tr><tr><td class="align_left">1</td><td class="align_center">Not available</td><td class="align_center">Elkind-Hirsch-1</td><td class="align_center">2008</td><td class="align_center">USA</td><td class="align_center">PCOS</td><td class="align_center">24</td></tr><tr><td class="align_left">2</td><td class="align_center">Not available</td><td class="align_center">Elkind-Hirsch-2</td><td class="align_center">2008</td><td class="align_center">USA</td><td class="align_center">PCOS</td><td class="align_center">24</td></tr><tr><td class="align_left">3</td><td class="align_center">NCT01911468</td><td class="align_center">Jensterle Sever-1</td><td class="align_center">2014</td><td class="align_center">Slovenia</td><td class="align_center">PCOS</td><td class="align_center">12</td></tr><tr><td class="align_left">4</td><td class="align_center">NCT01911468</td><td class="align_center">Jensterle Sever-2</td><td class="align_center">2014</td><td class="align_center">Slovenia</td><td class="align_center">PCOS</td><td class="align_center">12</td></tr><tr><td class="align_left">5</td><td class="align_center">NCT01899430</td><td class="align_center">Jensterle (a)</td><td class="align_center">2015</td><td class="align_center">Slovenia</td><td class="align_center">PCOS</td><td class="align_center">12</td></tr><tr><td class="align_left">6</td><td class="align_center">NCT02187250</td><td class="align_center">Jensterle (b)</td><td class="align_center">2015</td><td class="align_center">Slovenia</td><td class="align_center">PCOS</td><td class="align_center">12</td></tr><tr><td class="align_left">7</td><td class="align_center">ChiCTR-IIR-16008084</td><td class="align_center">Liu xin</td><td class="align_center">2017</td><td class="align_center">China</td><td class="align_center">PCOS</td><td class="align_center">12</td></tr><tr><td class="align_left">8</td><td class="align_center">NCT03353948</td><td class="align_center">Salamun</td><td class="align_center">2018</td><td class="align_center">Slovenia</td><td class="align_center">PCOS</td><td class="align_center">12</td></tr><tr class="table-tr"><td colspan="7"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Characteristics of the studies included in the meta-analysis.</div>

International Journal of Endocrinology

tab1

Table 1

Table 1: The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis 

Table 1 | The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis 